Register Here

Executive Sponsors

Adaptive Biotechnologies
Imaging Endpoints
Mitra Biotech
nanoString Technologies
NeoGenomics

Associate Sponsors

Apogenix
BeiGene
Bioclinica
Boston Immunetech
Cancer Genetics
Celyad
Cofactor Genomics
Cytel
Defined health
Exicure
ICON plc
KIYATEC Inc
IQVIA
Oncorus
PAREXEL
Personalis
Replimune
Smart Analyst

Exhibitors

Axio Research
Caprion
Intrinsic Imaging
Provecs Medical

Supporting & Educational Partners

Trout Group
CIMT
Cancer Research Institute CRI
Patient Empowerment Network PEN
SITC

Media Partners

BioCentury
BioPharm Insight
BioPharma Dive
CanBiotech
Endpoints News
Life Science Leader
Pharmalicensing
pharmaphorum
PharmaVOICE
STAT
Technology Networks

Overview

This is the 1st full day IO trials meeting in the US, led by the most experienced clinical operation professionals executing arguably the most difficult and important trials in the history of oncology.

Morning

The morning portion of the program is dedicated to new trends and collaborations in IO, followed by updates from the Biden Cancer initiative and the state of IO in Asia. Attendees will have access to quick-fire technology presentations and partnering meetings prior to lunch.

Featured Speakers

 

Andy Lee
Merck
Joho_StefanieStefanie Joho
Survivor and Advocate
Carol HaddadCarol Haddad
Merck
Chris LamplughChris Lamplugh
Merck
Patti ArsenaultPatti Arsenault
Cytel
Kamran AnsariKamran Ansari
Merck
Jacqueline Karmel
Roche
Bohnsack_OliverOliver Bohnsack,
MD, PhD, MBA

PAREXEL
Andrea Perrone, MD
Merck
Todd KisnerTodd Kisner
BioClinica
Cynthia GoldbergCynthia Goldberg, MD
PAREXEL
Neil StoddartNeil Stoddart
ICON plc

Afternoon

The afternoon covers the building blocks of IO trials, led by Andy Lee, SVP, Head of Global Clinical Trial Operations at Merck, including:

  • Patient Perspective with medical hero, Stephanie Joho
  • Site Management Nuts and Bolts with Claire Asogwa, Oncology Research Specialist, Merck
  • 3rd Party Component: Operational Aspects of PDL1 Stratification and Biomarkers, with Lisa Curtis, Relationship Manager, Merck and Jeff Hodge VP, Development Solutions, Oncology Center of Excellence, IQVIA
  • Clinical Supply Chain/Cold Chain with Carol Haddad, Director, Global Clinical Supply Planning, Merck
  • PI Perspective, TBA
  • Data Management: Principles with Chris Lamplugh, Senior Director, Clinical Data Management, Global Data Operations, Merck and Patti Arsenault, Executive Director, Global Head, Clinical Data Management, Cytel
  • Project Management: An Executive Perspective on what it Takes to Scale Up Resources with Kamran Ansari, AVP, Head of Oncology Clinical Sciences & Study Management, Global Clinical Trial Operations, Merck
  • The Operational Challenges of Combinations with Jacqueline Karmel, Principal Director, Scientific Collaborations, Roche
  • Operational Independent Reviews for IO Clinical Endpoints with Oliver Bohnsack, MD, PhD, MBA, Senior Director, Scientific and Medical Services, Head of Medical Relations Europe, Head of Oncology, PAREXEL

Additionally, attendees are welcome to join talks on Operational Aspects for Immunotherapy Imaging led by Andrea Perrone, MD, Associate VP, Clinical Imaging Translational MedicineMerck, including:

  • Inspection Readiness for Imaging Data with Todd Kisner, VP, Quality and Regulatory Affairs, BioClinica
  • Scientific and Medical Support For Managing Oncology Trials with Cynthia Goldberg, MD, Director, Scientific and Medical Services, PAREXEL
  • Outstanding Project Management with Neil Stoddart, Director, Clinical Operations, ICON plc
  • Large Pharma Imaging Panel Discussion moderated by Andrea Perrone, MD, with panelists Gregory Goldmacher, MD, PhD, MBA, Senior Director, Translational Biomarkers, Merck and David Leung, MD, PhD, Medical Director, Oncology Imaging, Exploratory Clinical & Translational Research, Bristol-Myers Squibb

The day will conclude with a networking cocktail reception.

IO Clinical Trials is part of the IO360˚ conference and is a great one day program for clinical trial operation professionals.  If you are already registered for IO360˚, this program is included. If you would like more information on IO360˚,  please click here.

Please contact us at service@tcfllc.org if you have any questions. Thank you and we look forward to seeing you in February.

Sincerely,​

kate-bw-3

Kate Woda
Conference Director

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Business Development

onaleesmith-bw

Onalee Smith
Marketing Manager

elizabeth-bard-bw-2

Elizabeth Bard
Business Development Manager

geeta-new-bw

Geeta Bachani
Business Development Manager

Bridget Halstead
Senior Conference Planner

Tara Fennelly
Marketing Associate